Patent Number: 8,877,175

Title: Long lasting drug formulations

Abstract: The present invention is directed to long-lasting erythropoietin therapeutic formulations and their methods of use wherein the formulation comprises a genetically modified micro-organ that comprises a vector which comprises a nucleic acid sequence operably linked to one or more regulatory sequences, wherein the nucleic acid sequence encodes erythropoietin.

Inventors: Pearlman; Andrew (D.N Misgav, IL), Stern; Baruch S. (Haifa, IL)

Assignee: Medgenics Medical Israel Ltd.

International Classification: A61K 35/12 (20060101); A61K 48/00 (20060101)

Expiration Date: 2019-11-04 0:00:00